Retham Technologies
Retham Technologies is a biotech company that provides a diagnosis of heparin induced thrombocytopenia by enabling rapid HIT testing.
$1.5M Seed ·
Led by Talents Fund · Source: linkedin.com
Funding history ↓Signals
Website registeredMay 19, 2017 (9 years old)
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Seed | $1.5M | linkedin.com |
Timeline
- Website created
Founders and team
AP
Anand Padmanabhan Founder
Investors
GGolden Angels Investors
MMilwaukee Venture Partners
NNational Institutes of Health
SSBIR Advance
TTalents Fundlead investor
Companies like Retham Technologies
IImmumem TherapeuticsPre Seed · May 2026
DDNAiTECH$605.6K Pre Seed · Oct 2024AAstratusSeed · Jun 2026
BBM DiagnosticsPre Seed · Apr 2026
AAllmadeSeed · Aug 2026
WWave LuminaSeed · Nov 2026
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/retham-technologies (get a free API key).